ALDEYRA THERAPEUTICS, INC. Accumulated Other Comprehensive Income
ALDEYRA THERAPEUTICS, INC. (ALDX) had Accumulated Other Comprehensive Income of $0 as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-02-27
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $815.00.
- 2025-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$10.99K.
- 2025-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.60K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-27 |
| 2025-09-30 | $815.00 10-Q · filed 2025-11-05 |
| 2025-06-30 | -$10.99K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.60K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $37.44K 10-K · filed 2026-02-27 |
| 2024-09-30 | $66.54K 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$9.66K 10-Q · filed 2024-08-01 |
| 2024-03-31 | -$3.03K 10-Q · filed 2024-05-02 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-03 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-03 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 |
| 2022-12-31 | -$103.94K 10-K · filed 2024-03-07 |
| 2022-09-30 | -$285.73K 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$285.76K 10-Q · filed 2022-08-05 |
| 2022-03-31 | -$61.68K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-09 |
| 2021-09-30 | $0.00 10-Q · filed 2021-10-28 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-17 |
| 2020-06-30 | $4.75K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $57.59K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $5.87K 10-K · filed 2021-03-11 |
| 2019-09-30 | $5.77K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $13.45K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $6.81K 10-Q · filed 2019-05-10 |
| 2018-12-31 | -$9.22K 10-K · filed 2020-03-12 |
| 2018-09-30 | -$5.20K 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$2.56K 10-Q · filed 2018-08-09 |
| 2018-03-31 | -$16.39K 10-Q · filed 2018-05-15 |
| 2017-12-31 | -$17.83K 10-K · filed 2019-03-08 |
| 2017-09-30 | -$1.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$4.64K 10-Q · filed 2017-08-07 |
| 2017-03-31 | -$4.75K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $129.00 10-K · filed 2018-03-29 |
| 2016-09-30 | $6.53K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $4.70K 10-Q · filed 2016-08-10 |
| 2016-03-31 | $1.80K 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$8.36K 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |